Evidence that the lipid phosphatase SHIP-1 regulates T lymphocyte morphology and motility

Journal of Immunology

Volumn 186, Issue 8, 2011, Pages 4936-4945

  Harris, Stephanie J ^a   Parry, Richard V ^a   Foster, John G ^a   Blunt, Matthew D ^a   Wang, Amu ^b   Marelli Berg, Federica ^b   Westwick, John ^c   Ward, Stephen G ^a  

^a University of Bath   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; CXCL11 CHEMOKINE; EZRIN; GLYCOGEN SYNTHASE KINASE 3BETA; LIPID PHOSPHATASE SHIP 1; MOESIN; PHOSPHATASE; PROTEIN KINASE B; RADIXIN; UNCLASSIFIED DRUG;

ACTIN POLYMERIZATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; CYTOSKELETON; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE STRUCTURE; MICROVILLUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

ACTINS; BLOTTING, WESTERN; CD4-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CHEMOKINE CXCL11; CYTOSKELETAL PROTEINS; CYTOSKELETON; FLOW CYTOMETRY; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MEMBRANE PROTEINS; MICROFILAMENT PROTEINS; MICROSCOPY, ELECTRON, SCANNING; MICROVILLI; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOLS; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 79955013111     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002350     Document Type: Article

References (71)

1. Huber, M., C. D. Helgason, J. E. Damen, L. Liu, R. K. Humphries, and G. Krystal. 1998. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. Proc. Natl. Acad. Sci. USA 95:11330-11335. (Pubitemid 28450128)
2. Neill, L., A. H. Tien, J. Rey-Ladino, and C. D. Helgason. 2007. SHIP-deficient mice provide insights into the regulation of dendritic cell development and function. Exp. Hematol. 35:627-639. (Pubitemid 46427971)
3. Nakamura, K., A. Malykhin, and K. M. Coggeshall. 2002. The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors. Blood 100:3374-3382. (Pubitemid 35217090)
4. Wahle, J. A., K. H. T. Paraiso, R. D. Kendig, H. R. Lawrence, L. Chen, J. Wu, and W. G. Kerr. 2007. Inappropriate recruitment and activity by the Src homology region 2 domain-containing phosphatase 1 (SHP1) is responsible for receptor dominance in the SHIP-deficient NK cell. J. Immunol. 179:8009-8015.
5. Antignano, F., M. Ibaraki, C. Kim, J. Ruschmann, A. Zhang, C. D. Helgason, and G. Krystal. 2010. SHIP is required for dendritic cell maturation. J. Immunol. 184:2805-2813.
6. Brauweiler, A. M., and J. C. Cambier. 2003. Fc gamma RIIB activation leads to inhibition of signalling by independently ligated receptors. Biochem. Soc. Trans. 31:281-285. (Pubitemid 36241445)
7. Ghansah, T., K. H. T. Paraiso, S. Highfill, C. Desponts, S. May, J. K. McIntosh, J.-W. Wang, J. Ninos, J. Brayer, F. Cheng, et al. 2004. Expansion of myeloid suppressor cells in SHIP-deficient mice represses allogeneic T cell responses. J. Immunol. 173:7324-7330. (Pubitemid 39628170)
8. Gabhann, J. N., R. Higgs, K. Brennan, W. Thomas, J. E. Damen, N. Ben Larbi, G. Krystal, and C. A. Jefferies. 2010. Absence of SHIP-1 results in constitutive phosphorylation of tank-binding kinase 1 and enhanced TLR3-dependent IFN-beta production. J. Immunol. 184:2314-2320.
9. Sly, L. M., M. J. Rauh, J. Kalesnikoff, C. H. Song, and G. Krystal. 2004. LPS-induced upregulation of SHIP is essential for endotoxin tolerance. Immunity 21:227-239. (Pubitemid 39094052)
10. Rodriguez, A., E. Vigorito, S. Clare, M. V. Warren, P. Couttet, D. R. Soond, S. van Dongen, R. J. Grocock, P. P. Das, E. A. Miska, et al. 2007. Requirement of bic/microRNA-155 for normal immune function. Science 316:608-611. (Pubitemid 46683148)
11. O'Connell, R. M., A. A. Chaudhuri, D. S. Rao, and D. Baltimore. 2009. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106:7113-7118.
12. Costinean, S., S. K. Sandhu, I. M. Pedersen, E. Tili, R. Trotta, D. Perrotti, D. Ciarlariello, P. Neviani, J. Harb, L. R. Kauffman, et al. 2009. Src homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic mice. Blood 114:1374-1382.
13. Helgason, C. D., J. E. Damen, P. Rosten, R. Grewal, P. Sorensen, S. M. Chappel, A. Borowski, F. Jirik, G. Krystal, and R. K. Humphries. 1998. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev. 12:1610-1620. (Pubitemid 28299513)
14. Edmunds, C., R. V. Parry, S. J. Burgess, B. Reaves, and S. G. Ward. 1999. CD28 stimulates tyrosine phosphorylation, cellular redistribution and catalytic activity of the inositol lipid 5-phosphatase SHIP. Eur. J. Immunol. 29:3507-3515. (Pubitemid 29527798)
15. Freeburn, R. W., K. L. Wright, S. J. Burgess, E. Astoul, D. A. Cantrell, and S. G. Ward. 2002. Evidence that SHIP-1 contributes to phosphatidylinositol 3, 4, 5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors. J. Immunol. 169:5441-5450. (Pubitemid 35291641)
16. Tomlinson, M. G., V. L. Heath, C. W. Turck, S. P. Watson, and A. Weiss. 2004. SHIP family inositol phosphatases interact with and negatively regulate the Tec tyrosine kinase. J. Biol. Chem. 279:55089-55096. (Pubitemid 40066501)
17. Dong, S., B. Corre, E. Foulon, E. Dufour, A. Veillette, O. Acuto, and F. Michel. 2006. T cell receptor for antigen induces linker for activation of T cell-dependent activation of a negative signaling complex involving Dok-2, SHIP-1, and Grb-2. J. Exp. Med. 203:2509-2518. (Pubitemid 44664620)
18. Gloire, G., E. Charlier, S. Rahmouni, C. Volanti, A. Chariot, C. Erneux, and J. Piette. 2006. Restoration of SHIP-1 activity in human leukemic cells modifies NF-[kappa]B activation pathway and cellular survival upon oxidative stress. Oncogene 25:5485-5494. (Pubitemid 44344099)
19. Chaigne-Delalande, B., G. Anies, I. Kramer, and E. Genot. 2008. Nonadherent cells switch to a Rac-mediated, SHIP regulated, Akt activation mode for survival. Oncogene 27:1876-1885. (Pubitemid 351430824)
20. Collazo, M. M., D. Wood, K. H. Paraiso, E. Lund, R. W. Engelman, C. T. Le, D. Stauch, K. Kotsch, and W. G. Kerr. 2009. SHIP limits immunoregulatory capacity in the T-cell compartment. Blood 113:2934-2944.
21. Kashiwada, M., G. Cattoretti, L. McKeag, T. Rouse, B. M. Showalter, U. Al-Alem, M. Niki, P. P. Pandolfi, E. H. Field, and P. B. Rothman. 2006. Downstream of tyrosine kinases-1 and Src homology 2-containing inositol 5′-phosphatase are required for regulation of CD4+CD25+ T cell development. J. Immunol. 176:3958-3965. (Pubitemid 44264373)
22. Locke, N. R., S. J. Patterson, M. J. Hamilton, L. M. Sly, G. Krystal, and M. K. Levings. 2009. SHIP regulates the reciprocal development of T regulatory and Th17 cells. J. Immunol. 183:975-983.
23. Tarasenko, T., H. K. Kole, A. W. Chi, M. M. Mentink-Kane, T. A. Wynn, and S. Bolland. 2007. T cell-specific deletion of the inositol phosphatase SHIP reveals its role in regulating Th1/Th2 and cytotoxic responses. Proc. Natl. Acad. Sci. USA 104:11382-11387. (Pubitemid 47175149)
24. Harris, S. J., R. V. Parry, J. Westwick, and S. G. Ward. 2008. Phosphoinositide lipid phosphatases: natural regulators of phosphoinositide 3-kinase signaling in T lymphocytes. J. Biol. Chem. 283:2465-2469.
25. Parry, R. V., S. J. Harris, and S. G. Ward. 2010. Fine tuning T lymphocytes: a role for the lipid phosphatase SHIP-1. Biochim. Biophys. Acta 1804:592-597.
26. Peng, T., T. R. Golub, and D. M. Sabatini. 2002. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol. Cell. Biol. 22:5575-5584. (Pubitemid 34755766)
27. Ward, S. G. 2004. Do phosphoinositide 3-kinases direct lymphocyte navigation? Trends Immunol. 25:67-74. (Pubitemid 38167487)
28. Ward, S. G. 2006. T lymphocytes on the move: chemokines, PI 3-kinase and beyond. Trends Immunol. 27:80-87. (Pubitemid 43221974)
29. Ward, S. G., and F. M. Marelli-Berg. 2009. Mechanisms of chemokine and antigen-dependent T-lymphocyte navigation. Biochem. J. 418:13-27.
30. Nishio, M., K. Watanabe, J. Sasaki, C. Taya, S. Takasuga, R. Iizuka, T. Balla, M. Yamazaki, H. Watanabe, R. Itoh, et al. 2007. Control of cell polarity and motility by the PtdIns (3, 4, 5) P3 phosphatase SHIP1. Nat. Cell Biol. 9:36-44. (Pubitemid 46024195)
31. Wain, C. M., J. Westwick, and S. G. Ward. 2005. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes. Cell. Signal. 17:1194-1202. (Pubitemid 40982610)
32. Dull, T., R. Zufferey, M. Kelly, R. J. Mandel, M. Nguyen, D. Trono, and L. Naldini. 1998. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:8463-8471. (Pubitemid 28471781)
33. Parry, R. V., C. A. Rumbley, L. H. Vandenberghe, C. H. June, and J. L. Riley. 2003. CD28 and inducible costimulatory protein Src homology 2 binding domains show distinct regulation of phosphatidylinositol 3-kinase, Bcl-xL, and IL-2 expression in primary human CD4 T lymphocytes. J. Immunol. 171:166-174. (Pubitemid 36745285)
34. Smith, L. D., E. S. Hickman, R. V. Parry, J. Westwick, and S. G. Ward. 2007. PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA. Cell. Signal. 19:2528-2539. (Pubitemid 47542298)
35. + T cells. J. Immunol. 162:696-703. (Pubitemid 29035389)
36. Alcázar, I., M. Marqués, A. Kumar, E. Hirsch, M. Wymann, A. C. Carrera, and D. F. Barber. 2007. Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation. J. Exp. Med. 204:2977-2987. (Pubitemid 350179565)
37. Ward, S. G., and D. A. Cantrell. 2001. Phosphoinositide 3-kinases in T lymphocyte activation. Curr. Opin. Immunol. 13:332-338. (Pubitemid 32537705)
38. Berlin, C., R. F. Bargatze, J. J. Campbell, U. H. von Andrian, M. C. Szabo, S. R. Hasslen, R. D. Nelson, E. L. Berg, S. L. Erlandsen, and E. C. Butcher. 1995. alpha 4 integrins mediate lymphocyte attachment and rolling under physiologic flow. Cell 80:413-422.
39. Brown, M. J., R. Nijhara, J. A. Hallam, M. Gignac, K. M. Yamada, S. L. Erlandsen, J. Delon, M. Kruhlak, and S. Shaw. 2003. Chemokine stimulation of human peripheral blood T lymphocytes induces rapid dephosphorylation of ERM proteins, which facilitates loss of microvilli and polarization. Blood 102:3890-3899. (Pubitemid 37486967)
40. Auvinen, E., N. Kivi, and A. Vaheri. 2007. Regulation of ezrin localization by Rac1 and PIPK in human epithelial cells. Exp. Cell Res. 313:824-833. (Pubitemid 46206076)
41. Nijhara, R., P. B. van Hennik, M. L. Gignac, M. J. Kruhlak, P. L. Hordijk, J. Delon, and S. Shaw. 2004. Rac1 mediates collapse of microvilli on chemokine-activated T lymphocytes. J. Immunol. 173:4985-4993. (Pubitemid 39387781)
42. Bretscher, A., D. Chambers, R. Nguyen, and D. Reczek. 2000. ERM-Merlin and EBP50 protein families in plasma membrane organization and function. Annu. Rev. Cell Dev. Biol. 16:113-143. (Pubitemid 32037502)
43. Schore, R. J., Y. Zheng, D. A. Williams, and Y. Gu. 2005. Inhibition of the Rho GTPase, Rac, differentially inhibits proliferation of AML cell lines and may serve as a novel molecular target. Blood (ASH Annual Meeting Abstracts) 106:1205.
44. Gao, Y., J. B. Dickerson, F. Guo, J. Zheng, and Y. Zheng. 2004. Rational design and characterization of a Rac GTPase-specific small molecule inhibitor. Proc. Natl. Acad. Sci. USA 101:7618-7623. (Pubitemid 38658078)
45. Kim, C. H., G. Hangoc, S. Cooper, C. D. Helgason, S. Yew, R. K. Humphries, G. Krystal, and H. E. Broxmeyer. 1999. Altered responsiveness to chemokines due to targeted disruption of SHIP. J. Clin. Invest. 104:1751-1759. (Pubitemid 30053192)
46. Abitorabi, M. A., R. K. Pachynski, R. E. Ferrando, M. Tidswell, and D. J. Erle. 1997. Presentation of integrins on leukocyte microvilli: a role for the extracellular domain in determining membrane localization. J. Cell Biol. 139:563-571. (Pubitemid 27459326)
47. Vanhaesebroeck, B., K. Ali, A. Bilancio, B. Geering, and L. C. Foukas. 2005. Signalling by PI3K isoforms: insights from gene-targeted mice. Trends Biochem. Sci. 30:194-204. (Pubitemid 40463309)
48. Okkenhaug, K., and B. Vanhaesebroeck. 2003. PI3K in lymphocyte development, differentiation and activation. Nat. Rev. Immunol. 3:317-330. (Pubitemid 37328684)
49. Cully, M., H. You, A. J. Levine, and T. W. Mak. 2006. Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat. Rev. Cancer 6:184-192. (Pubitemid 43292562)
50. Luo, J. M., H. Yoshida, S. Komura, N. Ohishi, L. Pan, K. Shigeno, I. Hanamura, K. Miura, S. Iida, R. Ueda, et al. 2003. Possible dominant-negative mutation of the SHIP gene in acute myeloid leukemia. Leukemia 17:1-8. (Pubitemid 36175881)
51. Sattler, M., R. Salgia, G. Shrikhande, S. Verma, J. L. Choi, L. R. Rohrschneider, and J. D. Griffin. 1997. The phosphatidylinositol polyphosphate 5-phosphatase SHIP and the protein tyrosine phosphatase SHP-2 form a complex in hematopoietic cells which can be regulated by BCR/ABL and growth factors. Oncogene 15:2379-2384. (Pubitemid 27496988)
52. Horn, S., E. Endl, B. Fehse, M. M. Weck, G. W. Mayr, and M. Jücker. 2004. Restoration of SHIP activity in a human leukemia cell line downregulates constitutively activated phosphatidylinositol 3-kinase/Akt/GSK-3beta signaling and leads to an increased transit time through the G1 phase of the cell cycle. Leukemia 18:1839-1849. (Pubitemid 39530015)
53. Lakhanpal, G. K., L. M. Vecchiarelli-Federico, Y.-J. Li, J.-W. Cui, M. L. Bailey, D. E. Spaner, D. J. Dumont, D. L. Barber, and Y. Ben-David. 2010. The inositol phosphatase SHIP-1 is negatively regulated by Fli-1 and its loss accelerates leukemogenesis. Blood 116:428-436.
54. Miletic, A. V., A. N. Anzelon-Mills, D. M. Mills, S. A. Omori, I. M. Pedersen, D. M. Shin, J. V. Ravetch, S. Bolland, H. C. Morse, III, and R. C. Rickert. 2010. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases. J. Exp. Med. 207:2407-2420.
55. Brooks, R., G. M. Fuhler, S. Iyer, M. J. Smith, M. Y. Park, K. H. Paraiso, R. W. Engelman, and W. G. Kerr. 2010. SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells. J. Immunol. 184:3582-3589.
56. Manning, B. D., and L. C. Cantley. 2007. AKT/PKB signaling: navigating downstream. Cell 129:1261-1274. (Pubitemid 46962095)
57. Ivetac, I., R. Gurung, S. Hakim, K. A. Horan, D. A. Sheffield, L. C. Binge, P. W. Majerus, T. Tiganis, and C. A. Mitchell. 2009. Regulation of PI (3) K/Akt signalling and cellular transformation by inositol polyphosphate 4-phosphatase-1. EMBO Rep. 10:487-493.
58. Gewinner, C., Z. C. Wang, A. Richardson, J. Teruya-Feldstein, D. Etemadmoghadam, D. Bowtell, J. Barretina, W. M. Lin, L. Rameh, L. Salmena, et al. 2009. Evidence that inositol polyphosphate 4-phosphatase type II is a tumor suppressor that inhibits PI3K signaling. Cancer Cell 16:115-125.
59. Charlier, E., C. Condé, J. Zhang, L. Deneubourg, E. Di Valentin, S. Rahmouni, A. Chariot, P. Agostinis, P. C. Pang, S. M. Haslam, et al. 2010. SHIP-1 inhibits CD95/APO-1/Fas-induced apoptosis in primary T lymphocytes and T leukemic cells by promoting CD95 glycosylation independently of its phosphatase activity. Leukemia 24:821-832.
60. Hogan, A., Y. Yakubchyk, J. Chabot, C. Obagi, E. Daher, K. Maekawa, and S. H. Gee. 2004. The phosphoinositol 3, 4-bisphosphate-binding protein TAPP1 interacts with syntrophins and regulates actin cytoskeletal organization. J. Biol. Chem. 279:53717-53724. (Pubitemid 40051880)
61. Costantini, J. L., S. M. Cheung, S. Hou, H. Li, S. K. Kung, J. B. Johnston, J. A. Wilkins, S. B. Gibson, and A. J. Marshall. 2009. TAPP2 links phosphoinositide 3-kinase signaling to B-cell adhesion through interaction with the cytoskeletal protein utrophin: expression of a novel cell adhesion-promoting complex in B-cell leukemia. Blood 114:4703-4712.
62. Arrieumerlou, C., E. Donnadieu, P. Brennan, G. Keryer, G. Bismuth, D. Cantrell, and A. Trautmann. 1998. Involvement of phosphoinositide 3-kinase and Rac in membrane ruffling induced by IL-2 in T cells. Eur. J. Immunol. 28:1877-1885. (Pubitemid 28271704)
63. Fleming, I. N., A. Gray, and C. P. Downes. 2000. Regulation of the Rac1-specific exchange factor Tiam1 involves both phosphoinositide 3-kinase-dependent and-independent components. Biochem. J. 351:173-182.
64. Ganesan, L. P., T. Joshi, H. Fang, V. K. Kutala, J. Roda, R. Trotta, A. Lehman, P. Kuppusamy, J. C. Byrd, W. E. Carson, et al. 2006. FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. Blood 108:718-725. (Pubitemid 44061375)
65. Tridandapani, S., G. W. Chacko, J. R. Van Brocklyn, and K. M. Coggeshall. 1997. Negative signaling in B cells causes reduced Ras activity by reducing Shc-Grb2 interactions. J. Immunol. 158:1125-1132. (Pubitemid 127469933)
66. Tamir, I., J. C. Stolpa, C. D. Helgason, K. Nakamura, P. Bruhns, M. Daeron, and J. C. Cambier. 2000. The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells. Immunity 12:347-358.
67. Pribila, J. T., A. C. Quale, K. L. Mueller, and Y. Shimizu. 2004. Integrins and T cell-mediated immunity. Annu. Rev. Immunol. 22:157-180. (Pubitemid 38680421)
68. Kay, R. R., P. Langridge, D. Traynor, and O. Hoeller. 2008. Changing directions in the study of chemotaxis. Nat. Rev. Mol. Cell Biol. 9:455-463. (Pubitemid 351733409)
69. Hoeller, O., and R. R. Kay. 2007. Chemotaxis in the absence of PIP3 gradients. Curr. Biol. 17:813-817. (Pubitemid 46635122)
70. Harris, S. J., J. G. Foster, and S. G. Ward. 2009. PI3K isoforms as drug targets in inflammatory diseases: lessons from pharmacological and genetic strategies. Curr. Opin. Investig. Drugs 10:1151-1162.
71. Ong, C. J., A. Ming-Lum, M. Nodwell, A. Ghanipour, L. Yang, D. E. Williams, J. Kim, L. Demirjian, P. Qasimi, J. Ruschmann, et al. 2007. Small molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells. Blood 110:1942-1949. (Pubitemid 47443908)